BloggingStocks

BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Closing Bell: The Rest of the World Doesn't Matter (AMZN, BBY, GME, MU, SFD, TEVA, PG)]]>http://www.bloggingstocks.com/2011/03/24/closing-bell-the-rest-of-the-world-doesnt-matter-amzn-bby-g/http://www.bloggingstocks.com/2011/03/24/closing-bell-the-rest-of-the-world-doesnt-matter-amzn-bby-g/http://www.bloggingstocks.com/2011/03/24/closing-bell-the-rest-of-the-world-doesnt-matter-amzn-bby-g/#commentsFiled under: Amazon.com (AMZN), Best Buy (BBY), GameStop Corp (GME)

Despite a weak durable goods figure this morning, despite more woes in Ireland and Portugal, and despite energy rising, the markets managed yet another gain. It is now almost back to 'international markets don't matter' in investor minds despite all of the risks and turmoil.

Here were today's closing bells:

Dow Jones 12,170.56 +84.54 (0.70%)
S&P 500 1,309.66 +12.12 (0.93%)
Nasdaq 2,736.42 +38.12 (1.41%)

Continue reading Closing Bell: The Rest of the World Doesn't Matter (AMZN, BBY, GME, MU, SFD, TEVA, PG)

Closing Bell: The Rest of the World Doesn't Matter (AMZN, BBY, GME, MU, SFD, TEVA, PG) originally appeared on BloggingStocks on Thu, 24 Mar 2011 16:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>AMZNBbyfeaturedGMEMUPGSFDTEVAThu, 24 Mar 2011 16:00:00 EST<![CDATA[Teva Pharmaceuticals Enters Partnership with Procter & Gamble]]>http://www.bloggingstocks.com/2011/03/24/teva-pharmaceuticals-enters-partnership-with-procter-and-gamble/http://www.bloggingstocks.com/2011/03/24/teva-pharmaceuticals-enters-partnership-with-procter-and-gamble/http://www.bloggingstocks.com/2011/03/24/teva-pharmaceuticals-enters-partnership-with-procter-and-gamble/#commentsFiled under: Deals, Procter and Gamble (PG), Options, Technical Analysis, Teva Pharm Indus ADR (TEVA)

Teva Pharmaceuticals (TEVA - option chain) shares are rising after the company announced it has signed an agreement with Proctor & Gamble (PG) to create a partnership that will combine both companies' over-the-counter medicine divisions. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on TEVA.

TEVA opened Thursday morning at $50.13. In morning trading, the stock hit a low of $49.86 and a high of $50.59. As of 12:20, TEVA was trading at $50.58 up $1.46 (3.0%). The chart for TEVA looks bullish and S&P gives TEVA a positive 4 stars (out of 5) buy ranking.

Continue reading Teva Pharmaceuticals Enters Partnership with Procter & Gamble

Teva Pharmaceuticals Enters Partnership with Procter & Gamble originally appeared on BloggingStocks on Thu, 24 Mar 2011 14:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>featuredinthenewsInvestors ObserveroptionsPGProcter and GambleTEVATeva PharmaceuticalsThu, 24 Mar 2011 14:00:00 EST<![CDATA[U.S. Stock Futures Flat as China's Central Bank Raises Interest Rates]]>http://www.bloggingstocks.com/2011/02/08/u-s-stock-futures-flat-as-chinas-central-bank-raises-interest/http://www.bloggingstocks.com/2011/02/08/u-s-stock-futures-flat-as-chinas-central-bank-raises-interest/http://www.bloggingstocks.com/2011/02/08/u-s-stock-futures-flat-as-chinas-central-bank-raises-interest/#commentsFiled under: Before the Bell, International Markets, Earnings Reports, Sara Lee Corp (SLE), Teva Pharm Indus ADR (TEVA)

U.S. stock futures are flat Tuesday morning after China's central bank raised interest rates. Futures on the Dow Jones Industrial Average rose 5 points to 12,113.00, and S&P 500 futures dropped 0.20 point to 1,315.60. Nasdaq 100 futures gained 0.50 point to 2,345.50.

U.S. stocks closed higher Monday, with the Dow gaining 0.57% to end the day at 12,162.

The NFIB index of small business optimism for January is due at 7:30 a.m. ET.

Continue reading U.S. Stock Futures Flat as China's Central Bank Raises Interest Rates

U.S. Stock Futures Flat as China's Central Bank Raises Interest Rates originally appeared on BloggingStocks on Tue, 08 Feb 2011 08:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>cncetrfuturesmfepremarketsletevaubsTue, 08 Feb 2011 08:30:00 EST<![CDATA[Chasing Value: 2011 Stock Picks -- Part 2]]>http://www.bloggingstocks.com/2010/12/27/chasing-value-2011-stock-picks-part-2/http://www.bloggingstocks.com/2010/12/27/chasing-value-2011-stock-picks-part-2/http://www.bloggingstocks.com/2010/12/27/chasing-value-2011-stock-picks-part-2/#commentsFiled under: Apple Inc (AAPL), General Electric (GE), Berkshire Hathaway (BRK.A), Diageo plc (DEO), Citigroup Inc. (C), Johnson and Johnson (JNJ), Novartis AG ADS (NVS), Chevron Corp (CVX), Teva Pharm Indus ADR (TEVA), China Life Insurance ADS (LFC), Bargain Stocks, Chasing Value[TM], Oil, Newcastle Investment (NCT), Raytheon Company (RTN), EZCORP (EZPW), Royal Dutch Shell (RDS.A), Telefonica SA (TEF), Noble Corporation (NE)

Could a stock that you made 1,100% on still have room to run? Yes, it is possible. In particular if it had a near death experience as a penny stock for a while.

That is the case with Newcastle Investments (NCT), the CMBS lender and real estate investment company that reached a recent high of $7.10 and has settled back down, most recently hovering between $6.70 to $7.00. It closed Thursday December 23 at $6.71.

Continue reading Chasing Value: 2011 Stock Picks -- Part 2

Chasing Value: 2011 Stock Picks -- Part 2 originally appeared on BloggingStocks on Mon, 27 Dec 2010 12:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>berkshire hathawayBRK.ABRK.BCChasingValueChevronChina Life InsuranceCitigroup Inc.DEODiageo plcEZCorp IncEZPWfeaturedGEgeneral electricJNJjohnson and johnsonLFCNCTNEnewcastle investmentNoble Corp.NovartisNVSoilRaytheon CompanyRDS.Aroyal dutch shellRTNTEFtelefonicaTEVATeva Pharmaceuticalswarren buffettMon, 27 Dec 2010 12:00:00 EST<![CDATA[Chasing Value: Pre-Christmas Quick Takes]]>http://www.bloggingstocks.com/2010/12/23/chasing-value-pre-christmas-quick-takes/http://www.bloggingstocks.com/2010/12/23/chasing-value-pre-christmas-quick-takes/http://www.bloggingstocks.com/2010/12/23/chasing-value-pre-christmas-quick-takes/#commentsFiled under: International Markets, Forecasts, Other Issues, General Electric (GE), Walgreen Co (WAG), Citigroup Inc. (C), JPMorgan Chase (JPM), Novartis AG ADS (NVS), Bank of America (BAC), Bank of New York (BK), CVS Corp (CVS), Goldman Sachs Group (GS), Teva Pharm Indus ADR (TEVA), Wells Fargo (WFC), Bargain Stocks, Chasing Value[TM], Travelers Companies Inc. (TRV)

To paraphrase Mark Twain "The reports of our death are greatly exaggerated". The world economy has been in shambles for a few years now, and our nation has much work ahead of it. 2010 was an improvement over 2009 and I believe 2011 will show further improvement.

There are lots of ideas running through my mind as I consider where the economy might be heading in 2011. What opportunities lay in front of us waiting to be picked up or passed over? Just five trading days left, and market activity will slow down except among fund managers making adjustments for tax purposes or window dressing. You should examine your tax situation, too.

Continue reading Chasing Value: Pre-Christmas Quick Takes

Chasing Value: Pre-Christmas Quick Takes originally appeared on BloggingStocks on Thu, 23 Dec 2010 13:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>BACBank of AmericaBKBNYCChasingValueChristmascitigroupCVSfeaturedGEgeneral electricGoldman SachsGSHCIIHomeowers Choice IncManulifeManulife FinancialMFCNovartisTEVAtravelers insuranceTRVWAGWalgreenwells fargoWFCThu, 23 Dec 2010 13:30:00 EST<![CDATA[Teva Pharmaceuticals MS Drug Study a Success]]>http://www.bloggingstocks.com/2010/12/09/teva-pharmaceuticals-ms-drug-study-a-success/http://www.bloggingstocks.com/2010/12/09/teva-pharmaceuticals-ms-drug-study-a-success/http://www.bloggingstocks.com/2010/12/09/teva-pharmaceuticals-ms-drug-study-a-success/#commentsFiled under: Major Movement, Good news, From the Boards, Options, Technical Analysis, Teva Pharm Indus ADR (TEVA), Israel

Teva Pharmaceuticals (TEVA - option chain) shares are rising today after the company announced this morning that a Phase 3 study of its multiple sclerosis drug laquinimod met its primary endpoint. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on TEVA.

TEVA opened this morning at $52.48. So far today the stock has hit a low of $51.96 and a high of $52.73. As of 11:55, TEVA is trading at $52.27 up $3.00 (6.1%). The chart for TEVA looks bullish and S&P gives TEVA a positive 4 STARS (out of 5) buy ranking

Continue reading Teva Pharmaceuticals MS Drug Study a Success

Teva Pharmaceuticals MS Drug Study a Success originally appeared on BloggingStocks on Thu, 09 Dec 2010 13:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>inthenewsInvestors ObserverlaquinimodMultiple SclerosisoptionsTEVATeva PharmaceuticalsThu, 09 Dec 2010 13:30:00 EST<![CDATA[Closing Bell: Bulls Say 'Who Cares!' on Europe and Jobs (BP, NBG, BRCD, TEVA, DRYS, MOT)]]>http://www.bloggingstocks.com/2010/12/03/closing-bell-bulls-say-who-cares-on-europe-and-jobs-bp-nbg/http://www.bloggingstocks.com/2010/12/03/closing-bell-bulls-say-who-cares-on-europe-and-jobs-bp-nbg/http://www.bloggingstocks.com/2010/12/03/closing-bell-bulls-say-who-cares-on-europe-and-jobs-bp-nbg/#commentsFiled under: Motorola (MOT), BP p.l.c. ADS (BP)

The markets looked like they were set for a bad day this morning, after the solid jobs data that was expected turned into a weakening jobs data. TrimTabs actually disputed that data and stocks rallied. The deficit panel also failed to win a super-majority vote. Amazingly, the markets rallied at the end of the day. That, and the rally of the two prior days, made this the best week in a month.

Here were the unofficial closing bell levels:

Dow Jones 11,382.09 +19.68 (0.17%)
S&P 500 1,224.71 +3.18 (0.26%)
Nasdaq 2,591.46 +12.11 (0.47%)

Continue reading Closing Bell: Bulls Say 'Who Cares!' on Europe and Jobs (BP, NBG, BRCD, TEVA, DRYS, MOT)

Closing Bell: Bulls Say 'Who Cares!' on Europe and Jobs (BP, NBG, BRCD, TEVA, DRYS, MOT) originally appeared on BloggingStocks on Fri, 03 Dec 2010 16:20:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>BPBRCDDRYSMOTTEVAFri, 03 Dec 2010 16:20:00 EST<![CDATA[Chasing Value: 2011 Stock Picks -- The Journey Begins]]>http://www.bloggingstocks.com/2010/12/02/chasing-value-2011-stock-picks-the-journey-begins/http://www.bloggingstocks.com/2010/12/02/chasing-value-2011-stock-picks-the-journey-begins/http://www.bloggingstocks.com/2010/12/02/chasing-value-2011-stock-picks-the-journey-begins/#commentsFiled under: Forecasts, Apple Inc (AAPL), General Electric (GE), Berkshire Hathaway (BRK.A), Diageo plc (DEO), Johnson and Johnson (JNJ), Novartis AG ADS (NVS), Teva Pharm Indus ADR (TEVA), China Life Insurance ADS (LFC), Chasing Value[TM], Israel, EZCORP (EZPW), Royal Dutch Shell (RDS.A), Telefonica SA (TEF)

Telefonica logo It's that time of year when I start thinking about my 2011 stock picks, and enough folks have been nudging me that I might as well get on with it. The list will not be finalized until the end of the month. During the interim time I will take readers through a number of possibilities, explaining the rational for my suggestions along the way and adding and subtracting until I get the list down to ten.

Today I will start by reviewing opportunities discussed in another post and determine which of these stocks might provide the best value. The list was originally cast as a globally diversified, large cap, dividend paying and relatively stable group of companies that would likely weather any storm. See: Chasing Value: Bonds, Gold, Stocks and Capital Flight

Continue reading Chasing Value: 2011 Stock Picks -- The Journey Begins

Chasing Value: 2011 Stock Picks -- The Journey Begins originally appeared on BloggingStocks on Thu, 02 Dec 2010 15:20:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>AAPLAppleberkshire hathawayChasingValueChina Life InsuranceDEOdiageoEZCorp IncEZPWfeaturedGEGeneralElectriciPadiPhoneJNJjohnson and johnsonLFCNovartisNVSrds.aroyal dutch shellTevaTeva Pharmaceuticalsverizon wirelessVZWarrenBuffettThu, 02 Dec 2010 15:20:00 EST<![CDATA[Chasing Value: Bonds, Gold, Stocks and Capital Flight]]>http://www.bloggingstocks.com/2010/11/15/chasing-value-bonds-gold-stocks-and-capital-flight/http://www.bloggingstocks.com/2010/11/15/chasing-value-bonds-gold-stocks-and-capital-flight/http://www.bloggingstocks.com/2010/11/15/chasing-value-bonds-gold-stocks-and-capital-flight/#commentsFiled under: International Markets, Competitive Strategy, General Electric (GE), China, Getting Started, Diageo plc (DEO), Johnson and Johnson (JNJ), Novartis AG ADS (NVS), Teva Pharm Indus ADR (TEVA), China Life Insurance ADS (LFC), Chasing Value[TM], Israel, Royal Dutch Shell (RDS.A), Telefonica SA (TEF)

It certainly is presumptuous, perhaps even self serving of me to assume the market is going higher in the face of so much uncertainty.

The reason I hold this belief is that so much money is sitting on the sidelines and much of it is getting restless. It's one thing for those on a fixed income to suffer because the Federal Reserve is keeping interest rates so low, but it is quite another thing to expect $2 trillion dollars of corporate cash to want to live like senior citizens. That cash is a bigger drag on earnings with each passing day.

Continue reading Chasing Value: Bonds, Gold, Stocks and Capital Flight

Chasing Value: Bonds, Gold, Stocks and Capital Flight originally appeared on BloggingStocks on Mon, 15 Nov 2010 16:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>bonds vs stocksChasingValueChina Life InsurancedeflationDEODiageoFederal reserveGEgeneral electricGoldinflationJNJjohnson and johnsonLFCNovartis AGNVSRDS.Aroyal dutch shellTEFtelefonicaTEVATeva PharmaceuticalsUS TreasuriesMon, 15 Nov 2010 16:30:00 EST<![CDATA[Week in Preview: Election, QE2, Unemployment and More Earnings]]>http://www.bloggingstocks.com/2010/10/31/week-in-preview-election-qe2-employment-and-more-earnings/http://www.bloggingstocks.com/2010/10/31/week-in-preview-election-qe2-employment-and-more-earnings/http://www.bloggingstocks.com/2010/10/31/week-in-preview-election-qe2-employment-and-more-earnings/#commentsFiled under: Earnings Reports, Forecasts, Starbucks (SBUX), Toyota Motor Corp. (TM), Economic Data, Teva Pharm Indus ADR (TEVA), Stocks to Buy, Federal Reserve, Marathon Oil (MRO)

earnings expectations It will be a busy week. Republicans are poised to gain control of the House of Representatives and gain governorships in Tuesday's mid-term elections. Also, the Federal Reserve is expected to announce another round of quantitative easing Wednesday, following the FOMC meeting. Major retailers are scheduled to report October same-store sales Thursday, while the October unemployment rate, announced on Friday, is expected to remain at 9.6%.

Toyota's (TM) fiscal second-quarter results will be one of the highlights on the earnings front this week. After three periods of way underestimating Toyota's earnings, have the analysts surveyed by Thomson Reuters got it right this time? The stock sure could use a boost. Teva Pharmaceuticals (TEVA) is in a similar situation; i.e., high expectations for this week's quarterly results but a stock in need of a boost. Marathon (MRO) and Starbucks (SBUX) are also expected to post strong earnings growth this week, but both stocks are riding high.

Continue reading Week in Preview: Election, QE2, Unemployment and More Earnings

Week in Preview: Election, QE2, Unemployment and More Earnings originally appeared on BloggingStocks on Sun, 31 Oct 2010 12:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>ADMAETanalyst forecastsBPCBSCLWRCLXCVSCVXDTVDVNearningsearnngs previewseconomic dataERTSfeaturedFederal ReserveFOMCFordGLWHMCISMKKFTMAMarathonMRONEMPFEPRUQCOMQE2quantitative easingRIGSAMSBUXSIRISMGStarbucksTAPTEVATMToyotaTSLATWXunemployment rateVMCWFMIWINNWLPWPIWPOWYNNXOMSun, 31 Oct 2010 12:30:00 EST<![CDATA[Deckers Outdoor Could Continue to Be a Winner]]>http://www.bloggingstocks.com/2010/10/27/deckers-outdoor-could-continue-to-be-a-winner/http://www.bloggingstocks.com/2010/10/27/deckers-outdoor-could-continue-to-be-a-winner/http://www.bloggingstocks.com/2010/10/27/deckers-outdoor-could-continue-to-be-a-winner/#commentsFiled under: Stocks to Buy

Deckers Outdoor (DECK) has been a winning investment regardless of the timeline. The stock has gained around 3,281% over the past 10 years, making it one of the top-performing stocks of the decade. During the past 52-weeks, DECK is up around 70%, and year-to-date the shares have jumped 64%.

Between 2006 and 2009, the company grew its revenue from $304 million to over $813 million. Net income went from $30.61 million to $116.79 million. DECK is set to release its earnings results on Thursday, October 26, after the closing bell. Wall Street analysts are projecting that the company will report earnings of 93 cents per share on revenue of $265.92 million.

Continue reading Deckers Outdoor Could Continue to Be a Winner

Deckers Outdoor Could Continue to Be a Winner originally appeared on BloggingStocks on Wed, 27 Oct 2010 12:20:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>deckDeckers Outdoorfeaturedtevaugg australiaWed, 27 Oct 2010 12:20:00 EST<![CDATA[Ben Graham Buys in Pharma: Gilead (GILD) and Teva (TEVA)]]>http://www.bloggingstocks.com/2010/10/14/gilead-and-teva-ben-graham-buys-in-pharma/http://www.bloggingstocks.com/2010/10/14/gilead-and-teva-ben-graham-buys-in-pharma/http://www.bloggingstocks.com/2010/10/14/gilead-and-teva-ben-graham-buys-in-pharma/#comments Teva logo

"Among our latest buy recommendations -- based on the value investing strategy of Ben Graham -- we like Gilead Sciences (GILD) and Teva Pharmaceutical (TEVA)," says J. Royden Ward.

The editor of Cabot Benjamin Graham Value Letter explains, "Gilead is a biopharmaceutical company that discovers, develops and markets therapeutic treatments to combat viral, bacterial and fungal infections. Its shares undervalued at 9.7 times forward 12-month EPS.

"Teva, based in Israel, develops, makes and sells generic and proprietary-branded (store brand) drugs. Its shares are clearly undervalued at 10.6 times forward EPS. We consider both stocks to be very low risk.

Continue reading Ben Graham Buys in Pharma: Gilead (GILD) and Teva (TEVA)

Ben Graham Buys in Pharma: Gilead (GILD) and Teva (TEVA) originally appeared on BloggingStocks on Thu, 14 Oct 2010 11:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>ben grahamcabot benjamin graham value letterdrug stocksfeaturedgeneric drug stocksGILDGilead Sciencesj. royden wardpharma stockspharmaceutical stockssteven halperntevaTeva Pharmaceuticalsthestockadvisors.comvalue investingvalue stocksThu, 14 Oct 2010 11:00:00 EST<![CDATA[Analyst Calls: AMGN, APOL, CE, CELG, HGSI, RIMM, STXS, SUN, TEVA, VAL ...]]>http://www.bloggingstocks.com/2010/09/09/analyst-upgrades-downgrades/http://www.bloggingstocks.com/2010/09/09/analyst-upgrades-downgrades/http://www.bloggingstocks.com/2010/09/09/analyst-upgrades-downgrades/#commentsFiled under: Analyst Reports, Analyst Upgrades and Downgrades, American Express (AXP), BB and T (BBT), Research in Motion (RIMM), Analyst Initiations, Teva Pharm Indus ADR (TEVA), Gilead Sciences (GILD), Lloyds TSB Group plc ADS (LYG)

Analyst Upgrades

Continue reading Analyst Calls: AMGN, APOL, CE, CELG, HGSI, RIMM, STXS, SUN, TEVA, VAL ...

Analyst Calls: AMGN, APOL, CE, CELG, HGSI, RIMM, STXS, SUN, TEVA, VAL ... originally appeared on BloggingStocks on Thu, 09 Sep 2010 11:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>AMGNanalyst upgradesAPOLApollo GroupBBTCECELGdowngradesEDMCESIEXASGILDGileadHGSIinitiationsinthenewsLYGMPELNVSResearch In MotionRIMMSEHSSCCSTXSSUNTellabsTEVATINTLABVALThu, 09 Sep 2010 11:30:00 EST<![CDATA[Ben Graham Values: Ten Conservative Growth and Income Ideas]]>http://www.bloggingstocks.com/2010/07/28/ben-graham-values-10-conservative-growth-and-income-ideas/http://www.bloggingstocks.com/2010/07/28/ben-graham-values-10-conservative-growth-and-income-ideas/http://www.bloggingstocks.com/2010/07/28/ben-graham-values-10-conservative-growth-and-income-ideas/#commentsFiled under: Wal-Mart (WMT), PepsiCo (PEP), Newsletters, McDonald's (MCD), International Business Machines (IBM), Walgreen Co (WAG), Johnson and Johnson (JNJ), Colgate-Palmolive (CL), Oracle Corp (ORCL), Teva Pharm Indus ADR (TEVA), Stocks to Buy

"Investing in conservative stocks to build or rebuild the core of your portfolio makes sense right now; investors should buy companies that have a long history of steady earnings and dividend growth, through good times and tough times," says J. Royden Ward.

The editor of the specialty newsletter, Cabot Benjamin Graham Value Letter, explains, "The obvious beneﬁt of adhering to a disciplined system of value investing like ours is that you build long-term proﬁts and, ideally, ﬁnancial independence.

Continue reading Ben Graham Values: Ten Conservative Growth and Income Ideas

Ben Graham Values: Ten Conservative Growth and Income Ideas originally appeared on BloggingStocks on Wed, 28 Jul 2010 10:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>ben grahambenjamin grahamcabot benjamin graham value lettercolgate-palmolivedividend stocksfeaturedibmincome stocksj. royden wardjnjMCDmcdonaldsoraclepeppepsicosteven halperntevaTeva Pharmaceuticalsthestockadvisors.comvalue stockswal-martwalgreenWMTyield stocksWed, 28 Jul 2010 10:00:00 EST<![CDATA[Analyst Calls: BX, CBOE, DO, EL, INTU, ITT, PTEN, RNST, T, TEVA ...]]>http://www.bloggingstocks.com/2010/07/26/analyst-upgrades-downgrades/http://www.bloggingstocks.com/2010/07/26/analyst-upgrades-downgrades/http://www.bloggingstocks.com/2010/07/26/analyst-upgrades-downgrades/#commentsFiled under: Analyst Reports, Analyst Upgrades and Downgrades, AT and T (T), Intuit Inc (INTU), Analyst Initiations, Teva Pharm Indus ADR (TEVA), Blackstone Group L.P (BX)

Analyst Upgrades

Berstein upgraded Diamond Offshore (DO) to market perform from underperform based on valuation. The firm has a $69 price target on the stock.
Jefferies upgraded Patterson-UTI Energy (PTEN) to buy from hold, citing leverage to higher land rig pricing. The firm raised its price target to $21 from $17.
Wunderlich upgraded Renasant (RNST) to buy from hold following the company's acquisition of Crescent Bank. The firm raised its target for shares to $20 from $15.
AT&T (T) was upgraded to buy from hold at Deutsche Bank.
Blackstone (BX) was upgraded to buy from neutral at BofA/Merrill.
Scripps Networks (SNI) was upgraded to overweight from equal weight at Morgan Stanley.

Continue reading Analyst Calls: BX, CBOE, DO, EL, INTU, ITT, PTEN, RNST, T, TEVA ...

Analyst Calls: BX, CBOE, DO, EL, INTU, ITT, PTEN, RNST, T, TEVA ... originally appeared on BloggingStocks on Mon, 26 Jul 2010 11:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>AEPAMMDanalyst upgradesBSFTBXCBOEDOdowngradesELFiatinthenewsintiationsINTUITTLULUSAFMSIVBSNITevaMon, 26 Jul 2010 11:00:00 EST<![CDATA[Five Popular Penny Stocks to Sell Now]]>http://www.bloggingstocks.com/2010/07/20/five-popular-penny-stocks-to-sell-now/http://www.bloggingstocks.com/2010/07/20/five-popular-penny-stocks-to-sell-now/http://www.bloggingstocks.com/2010/07/20/five-popular-penny-stocks-to-sell-now/#commentsFiled under: Stocks to Sell

When it comes to buying inexpensive stocks, sometimes investors think that they can find bargains for just a few dollars a share. Sometimes they are right -- but other times these penny stocks can expose your portfolio to big risk and lose you a bundle in a hurry. Here are five popular stocks under $2 a share you should avoid like the plague.

Penny stock investing tends to be riskier than investing in large cap stocks, but that doesn't mean you have to settle for losers in your quest for big penny stocks that take off. Here are five penny stock losers to avoid:

Continue reading Five Popular Penny Stocks to Sell Now

Five Popular Penny Stocks to Sell Now originally appeared on BloggingStocks on Tue, 20 Jul 2010 14:15:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>aclsaisfeaturedibmicogintcpenny stocksrameStocks to SelltevatsemtxnTue, 20 Jul 2010 14:15:00 EST<![CDATA[Teva (TEVA): A 'Sure Pick' for the Long-Term]]>http://www.bloggingstocks.com/2010/07/20/teva-teva-a-sure-pick-for-the-long-term/http://www.bloggingstocks.com/2010/07/20/teva-teva-a-sure-pick-for-the-long-term/http://www.bloggingstocks.com/2010/07/20/teva-teva-a-sure-pick-for-the-long-term/#commentsFiled under: Newsletters, Teva Pharm Indus ADR (TEVA), Stocks to Buy, Israel

"With a sprawling portfolio of 409 different remedies, Teva Pharmaceuticals (TEVA) is easily the world's largest generic drug maker -- and unless people suddenly stop getting sick, Teva is one of the surest picks around for long-term investors," says Nathan Slaughter.

The editor of Street Authority Market Advisor explains, "Teva is more than double the size of its closest rival in terms of both product breadth and market share.

"But even for a company of Teva's size, product No. 410 is a biggie. The firm recently introduced Venlafaxine, a generic version of Pfizer's anti-depressant Effexor.

Continue reading Teva (TEVA): A 'Sure Pick' for the Long-Term

Teva (TEVA): A 'Sure Pick' for the Long-Term originally appeared on BloggingStocks on Tue, 20 Jul 2010 12:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>drug stocksgeneric drug stockshealthcare stocksisrael stocksnathan slaughterstreet authority market advisortevathestockadvisors.comTue, 20 Jul 2010 12:30:00 EST<![CDATA[Five Global Favorites: 'Time to Buy']]>http://www.bloggingstocks.com/2010/05/27/five-global-favorites-cx-ccj-cch-teva-ibn/http://www.bloggingstocks.com/2010/05/27/five-global-favorites-cx-ccj-cch-teva-ibn/http://www.bloggingstocks.com/2010/05/27/five-global-favorites-cx-ccj-cch-teva-ibn/#commentsFiled under: International Markets, India, Newsletters, Mexico, Canada, Teva Pharm Indus ADR (TEVA), Commodities, Stocks to Buy, Israel, CEMEX S.A.B. de C.V. (CX), ICICI Bank (IBN)

"Given the stock market setback, the time to buy has come. So what is a global investor to do now? Where in the world do we go?" asks Vivian Lewis.

The editor of Global Investing reviews five global investment ideas: Mexico's Cemex (CX), Canada's Cameco (CCJ), Greece's Coca Cola Hellenic (CCH), Israel's Teva Pharmaceutcial (TEVA), and India's ICICI Bank (IBN).

"I think this May correction has been the result of insane blind total panic in the wake of the still unexplained flash crash. Logically nothing explains the sell-off -- nada, nichevo, nichts, rien. To imagine that Greece is going to pull down Britain, Germany and France is simply ridiculous.

Continue reading Five Global Favorites: 'Time to Buy'

Five Global Favorites: 'Time to Buy' originally appeared on BloggingStocks on Thu, 27 May 2010 12:40:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>camecoccjCoca Cola Hellenic BottlingcxfeaturedGlobal Investingglobal stocksibnicici banksteven halperntevateva pharmaceuticalthestockadvisors.comVivian LewisThu, 27 May 2010 12:40:00 EST<![CDATA[Analyst Calls: AAPL, DWA, INTU, NFLX, PSYS, PVH, ROSE, TEVA, UNCA ...]]>http://www.bloggingstocks.com/2010/05/18/analyst-calls-aapl-dwa-intu-nflx/http://www.bloggingstocks.com/2010/05/18/analyst-calls-aapl-dwa-intu-nflx/http://www.bloggingstocks.com/2010/05/18/analyst-calls-aapl-dwa-intu-nflx/#commentsFiled under: Analyst Reports, Analyst Upgrades and Downgrades, Apple Inc (AAPL), Netflix, Inc. (NFLX), Intuit Inc (INTU), Analyst Initiations, Teva Pharm Indus ADR (TEVA), DreamWorks Animation (DWA)

Analyst Upgrades

Piper Jaffray upgraded Psychiatric Solutions (PSYS) to neutral from underweight on expectations the company's merger with Universal Health (UHS) will close.
Jefferies upgraded Intuit (INTU) to buy from neutral and has a $45 price target on the stock. The firm expects Intuit's 2011 tax season to be at least as good as 2010's and sees improvement in the SMB exposed businesses.
Wells Fargo upgraded Unica (UNCA) to outperform from market perform. The firm upgraded the stock due to what it sees as improving trends in marketing spending, upcoming enhancements in the company's products and long-term opportunity for marketing software to exceed expectations.
Textron (TXT) was upgraded to conviction buy from buy at Goldman.
RightNow (RNOW) was upgraded to outperform from market perform at FBR Capital.
Beazer Homes (BZH) was upgraded to buy from hold at Citigroup.

Continue reading Analyst Calls: AAPL, DWA, INTU, NFLX, PSYS, PVH, ROSE, TEVA, UNCA ...

Analyst Calls: AAPL, DWA, INTU, NFLX, PSYS, PVH, ROSE, TEVA, UNCA ... originally appeared on BloggingStocks on Tue, 18 May 2010 11:40:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>AAPLAIZanalyst upgradesAppleBUCYBucyrusBZHCRICdowngradesDreameworksDWAGLGinitiationsinthenewsINTUIntuitNetflixNFLXPSYSPVHRNOWROSETEVATXTUNCAVSECTue, 18 May 2010 11:40:00 EST<![CDATA[Teva (TEVA): Generic Gains from Health Care Reform]]>http://www.bloggingstocks.com/2010/05/13/teva-teva-generic-gains-from-healthcare-reform/http://www.bloggingstocks.com/2010/05/13/teva-teva-generic-gains-from-healthcare-reform/http://www.bloggingstocks.com/2010/05/13/teva-teva-generic-gains-from-healthcare-reform/#commentsFiled under: Newsletters, Teva Pharm Indus ADR (TEVA), Stocks to Buy, Israel

"Now that health care reform has become law, what will it mean for investors in health care-related companies? One company that is likely to be among the biggest beneficiaries is Teva Pharmaceutical (TEVA)," says Stephen Leeb.

The editor of The Complete Investor explains, "With 32 million Americans gaining health insurance coverage , the reform package is certain to accelerate the growing use of generic drugs, a trend rooted both in demographics and in the push to cut costs.

"Generic drugs already benefit from our aging population, who take more drugs by the year. The additional numbers of insured Americans will mean a surge in people able to afford medications (and to see the doctors that prescribe them).

Continue reading Teva (TEVA): Generic Gains from Health Care Reform

Teva (TEVA): Generic Gains from Health Care Reform originally appeared on BloggingStocks on Thu, 13 May 2010 14:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>complete investordrug stocksfeaturedgeneric drug stocksgeneric drugsstephen leebsteven halperntevaTeva Pharmaceuticalsthestockadvisors.comThu, 13 May 2010 14:00:00 EST